Paratek Pharmaceuticals, Inc.
PRTKDelisted Sep 21, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001178711
Paratek Pharmaceuticals, Inc. was delisted on Sep 21, 2023; its insiders filed their last Form 4 on Sep 21, 2023; 66 institutions reported holding it in 13F filings for Q2 2023, worth $47.0M in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Paratek Pharmaceuticals, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 107 | 116 | +9 |
| Shares | 24.0M | 24.4M | +423.2K (+1.8%) |
| Value | $169.4M | $166.5M | −$2.89M (−1.7%) |
New holders (24)
Institutions that held Paratek Pharmaceuticals, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (15)
Institutions that held Paratek Pharmaceuticals, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| California Public Employees Retirement System | 88,700 | $626.0K |
| Jacobs Levy Equity Management, Inc | 63,210 | $446.0K |
| Russell Investments Group, Ltd. | 42,024 | $295.0K |
| Occudo Quantitative Strategies LP | 28,530 | $201.0K |
| Boothbay Fund Management, LLC | 16,000 | $113.0K |
| XTX Topco Ltd | 15,425 | $109.0K |
| Acadian Asset Management LLC | 15,001 | $106.0K |
| Gamco Investors, Inc. Et Al | 13,000 | $92.0K |
| Metropolitan Life Insurance Co | 12,212 | $86.2K |
| Virtu Financial LLC | 10,194 | $72.0K |
| MetLife Investment Management | 4,634 | $32.7K |
| Bank of Montreal | 2,692 | $18.0K |
| WealthShield Partners, LLC | 2,500 | $18.0K |
| Federated Hermes, Inc. | 319 | $2.00K |
| Sowell Financial Services LLC | 100 | $1.00K |